Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 78.20
+1.40 (1.82%)
Oct 28, 2026, 10:38 AM HKT
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 13.11 billion as of October 27, 2026. It is the 7,506th most valuable company in the world and the 373rd biggest in Hong Kong.
Market Cap
13.11B
Enterprise Value
13.62B
Revenue
250.82M
Global Rank
Country Rank
#373 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has decreased from 13.74B to 13.11B, a decrease of -4.63%. That is a compound annual growth rate of -4.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 13.24B | -3.48% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 336.72B |
| Hansoh Pharmaceutical Group Company | 200.07B |
| WuXi Biologics | 187.95B |
| Innovent Biologics | 144.84B |
| Angelalign Technology | 13.88B |
| CanSino Biologics | 13.85B |
| Duality Biotherapeutics | 13.55B |
| The United Laboratories International Holdings | 13.46B |